Ligand Pharmaceutical Inc (LGND) Com Stk Class 'B' USD0.001
Sell:$102.43Buy:$133.63
$0.11
(0.09%)
NASDAQ:
0.25%
0.25%Market closed | Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$102.43
Buy:$133.63
Change:$0.11
(0.09%)
$0.11
(0.09%)Market closed | Prices delayed by at least 15 minutes
Sell:$102.43
Buy:$133.63
Change:$0.11
(0.09%)
$0.11
(0.09%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 23 December 2024 | Octavio EspinozaCFO | Sell Regular sell transaction (market) | 2,104 | $116.37 | $244,850.48 | 20,647 |
| 5 December 2024 | Octavio EspinozaCFO | Sell Tax related | 1,859 | $123.51 | $229,605.09 | 22,751 |
| 27 November 2024 | John L. LaMattinaIndependent Director | Sell Option/Award related | 2,406 | $123.65 | $297,501.90 | 29,515 |
| 23 September 2024 | Matthew E KorenbergPresident/COO | Sell Option/Award related | 2,481 | $100.05 | $248,228.27 | 58,068 |
| 23 September 2024 | Matthew E KorenbergPresident/COO | Sell Option/Award related | 7,090 | $101.61 | $720,379.45 | 50,978 |
| 23 September 2024 | Matthew E KorenbergPresident/COO | Sell Option/Award related | 201 | $102.05 | $20,512.87 | 50,777 |
| 23 September 2024 | Andrew Thomas ReardonChief Legal/Compliance Officer | Sell Option/Award related | 2,000 | $99.60 | $199,201.00 | 22,534 |
| 20 September 2024 | Matthew E KorenbergPresident/COO | Sell Option/Award related | 6,275 | $104.10 | $653,238.17 | 50,777 |
| 20 September 2024 | Octavio EspinozaCFO | Sell Regular sell transaction (market) | 200 | $103.98 | $20,796.00 | 25,685 |
| 20 September 2024 | Octavio EspinozaCFO | Sell Regular sell transaction (market) | 275 | $103.86 | $28,562.19 | 25,410 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 9 August 2024 | Matthew E KorenbergPresident/COO | Sell Regular sell transaction (market) | 18,245 | $98.50 | $1,797,132.50 | 68,368 |
| 14 May 2024 | Matthew E KorenbergPresident/COO | Sell Regular sell transaction (market) | 13,638 | $85.08 | $1,160,356.50 | 86,783 |
| 9 May 2024 | Andrew Thomas ReardonChief Legal/Compliance Officer | Sell Option/Award related | 10,000 | $83.04 | $830,449.00 | 22,205 |
| 23 September 2024 | Matthew E KorenbergPresident/COO | Sell Option/Award related | 7,090 | $101.61 | $720,379.45 | 50,978 |
| 20 September 2024 | Matthew E KorenbergPresident/COO | Sell Option/Award related | 6,275 | $104.10 | $653,238.17 | 50,777 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.